Annual Shareholders Equity
$152.61 M
+$10.60 M+7.46%
31 December 2023
Summary:
MacroGenics annual stockholders equity is currently $152.61 million, with the most recent change of +$10.60 million (+7.46%) on 31 December 2023. During the last 3 years, it has fallen by -$143.27 million (-48.42%). MGNX annual shareholders equity is now -51.29% below its all-time high of $313.34 million, reached on 31 December 2015.MGNX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$120.07 M
+$62.25 M+107.66%
30 September 2024
Summary:
MacroGenics quarterly stockholders equity is currently $120.07 million, with the most recent change of +$62.25 million (+107.66%) on 30 September 2024. Over the past year, it has dropped by -$73.91 million (-38.10%). MGNX quarterly shareholders equity is now -65.75% below its all-time high of $350.53 million, reached on 31 March 2021.MGNX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGNX Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.5% | -38.1% |
3 y3 years | -48.4% | -58.8% |
5 y5 years | -37.2% | -53.0% |
MGNX Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -48.4% | +7.5% | -58.8% | +107.7% |
5 y | 5 years | -48.4% | +7.5% | -65.8% | +107.7% |
alltime | all time | -51.3% | +972.9% | -65.8% | +1198.5% |
MacroGenics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $120.07 M(+107.7%) |
June 2024 | - | $57.82 M(-45.5%) |
Mar 2024 | - | $106.15 M(-30.4%) |
Dec 2023 | $152.61 M(+7.5%) | $152.61 M(-21.3%) |
Sept 2023 | - | $193.98 M(+13.1%) |
June 2023 | - | $171.54 M(+57.0%) |
Mar 2023 | - | $109.27 M(-23.1%) |
Dec 2022 | $142.01 M(-40.7%) | $142.01 M(+15.5%) |
Sept 2022 | - | $122.96 M(-13.7%) |
June 2022 | - | $142.48 M(-20.1%) |
Mar 2022 | - | $178.21 M(-25.6%) |
Dec 2021 | $239.62 M(-19.0%) | $239.62 M(-17.8%) |
Sept 2021 | - | $291.44 M(-8.7%) |
June 2021 | - | $319.05 M(-9.0%) |
Mar 2021 | - | $350.53 M(+18.5%) |
Dec 2020 | $295.88 M(+28.3%) | $295.88 M(+1.5%) |
Sept 2020 | - | $291.58 M(+17.7%) |
June 2020 | - | $247.78 M(+30.0%) |
Mar 2020 | - | $190.57 M(-17.4%) |
Dec 2019 | $230.63 M(-5.0%) | $230.63 M(-9.6%) |
Sept 2019 | - | $255.20 M(-13.3%) |
June 2019 | - | $294.45 M(-8.2%) |
Mar 2019 | - | $320.62 M(+32.0%) |
Dec 2018 | $242.88 M | $242.88 M(-14.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | $282.64 M(-9.4%) |
June 2018 | - | $312.04 M(+26.2%) |
Mar 2018 | - | $247.28 M(-17.4%) |
Dec 2017 | $299.24 M(+11.3%) | $299.24 M(+57.9%) |
Sept 2017 | - | $189.47 M(-18.1%) |
June 2017 | - | $231.35 M(-1.4%) |
Mar 2017 | - | $234.64 M(-12.7%) |
Dec 2016 | $268.75 M(-14.2%) | $268.75 M(-10.4%) |
Sept 2016 | - | $300.10 M(-9.1%) |
June 2016 | - | $329.98 M(+15.3%) |
Mar 2016 | - | $286.25 M(-8.6%) |
Dec 2015 | $313.34 M(+158.3%) | $313.34 M(-7.7%) |
Sept 2015 | - | $339.33 M(+60.3%) |
June 2015 | - | $211.69 M(-8.4%) |
Mar 2015 | - | $230.99 M(+90.5%) |
Dec 2014 | $121.29 M(+53.7%) | $121.29 M(-12.8%) |
Sept 2014 | - | $139.09 M(-2.0%) |
June 2014 | - | $141.98 M(-7.3%) |
Mar 2014 | - | $153.22 M(+94.2%) |
Dec 2013 | $78.91 M(-1058.0%) | $78.91 M(-2049.3%) |
Sept 2013 | - | -$4.05 M(-63.0%) |
June 2013 | - | -$10.93 M(+32.7%) |
Dec 2012 | -$8.24 M(-52.9%) | -$8.24 M |
Dec 2011 | -$17.48 M | - |
FAQ
- What is MacroGenics annual stockholders equity?
- What is the all time high annual shareholders equity for MacroGenics?
- What is MacroGenics annual shareholders equity year-on-year change?
- What is MacroGenics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for MacroGenics?
- What is MacroGenics quarterly shareholders equity year-on-year change?
What is MacroGenics annual stockholders equity?
The current annual shareholders equity of MGNX is $152.61 M
What is the all time high annual shareholders equity for MacroGenics?
MacroGenics all-time high annual stockholders equity is $313.34 M
What is MacroGenics annual shareholders equity year-on-year change?
Over the past year, MGNX annual stockholders equity has changed by +$10.60 M (+7.46%)
What is MacroGenics quarterly stockholders equity?
The current quarterly shareholders equity of MGNX is $120.07 M
What is the all time high quarterly shareholders equity for MacroGenics?
MacroGenics all-time high quarterly stockholders equity is $350.53 M
What is MacroGenics quarterly shareholders equity year-on-year change?
Over the past year, MGNX quarterly stockholders equity has changed by -$73.91 M (-38.10%)